rs112133109

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001166114.2(PNPLA6):​c.3603G>A​(p.Gln1201Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0125 in 1,614,218 control chromosomes in the GnomAD database, including 153 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0092 ( 13 hom., cov: 33)
Exomes 𝑓: 0.013 ( 140 hom. )

Consequence

PNPLA6
NM_001166114.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.68

Publications

7 publications found
Variant links:
Genes affected
PNPLA6 (HGNC:16268): (patatin like phospholipase domain containing 6) This gene encodes a phospholipase that deacetylates intracellular phosphatidylcholine to produce glycerophosphocholine. It is thought to function in neurite outgrowth and process elongation during neuronal differentiation. The protein is anchored to the cytoplasmic face of the endoplasmic reticulum in both neurons and non-neuronal cells. Mutations in this gene result in autosomal recessive spastic paraplegia, and the protein is the target for neurodegeneration induced by organophosphorus compounds and chemical warfare agents. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
PNPLA6 Gene-Disease associations (from GenCC):
  • ataxia-hypogonadism-choroidal dystrophy syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • PNPLA6-related spastic paraplegia with or without ataxia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 39
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • cerebellar ataxia-hypogonadism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Laurence-Moon syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • trichomegaly-retina pigmentary degeneration-dwarfism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 19-7559055-G-A is Benign according to our data. Variant chr19-7559055-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 240699.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.68 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00918 (1399/152356) while in subpopulation NFE AF = 0.0137 (933/68028). AF 95% confidence interval is 0.013. There are 13 homozygotes in GnomAd4. There are 677 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001166114.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNPLA6
NM_001166114.2
MANE Select
c.3603G>Ap.Gln1201Gln
synonymous
Exon 28 of 32NP_001159586.1A0A384DVU0
PNPLA6
NM_001166111.2
c.3633G>Ap.Gln1211Gln
synonymous
Exon 30 of 34NP_001159583.1Q8IY17-4
PNPLA6
NM_001166113.1
c.3489G>Ap.Gln1163Gln
synonymous
Exon 31 of 35NP_001159585.1Q8IY17-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNPLA6
ENST00000600737.6
TSL:1 MANE Select
c.3603G>Ap.Gln1201Gln
synonymous
Exon 28 of 32ENSP00000473211.1A0A384DVU0
PNPLA6
ENST00000221249.10
TSL:1
c.3489G>Ap.Gln1163Gln
synonymous
Exon 31 of 35ENSP00000221249.5Q8IY17-2
PNPLA6
ENST00000450331.7
TSL:1
c.3489G>Ap.Gln1163Gln
synonymous
Exon 31 of 35ENSP00000394348.2Q8IY17-2

Frequencies

GnomAD3 genomes
AF:
0.00921
AC:
1402
AN:
152238
Hom.:
13
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00248
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.00896
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00517
Gnomad FIN
AF:
0.0124
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0137
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.0106
AC:
2661
AN:
251440
AF XY:
0.0115
show subpopulations
Gnomad AFR exome
AF:
0.00339
Gnomad AMR exome
AF:
0.00627
Gnomad ASJ exome
AF:
0.00536
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0134
Gnomad NFE exome
AF:
0.0155
Gnomad OTH exome
AF:
0.00978
GnomAD4 exome
AF:
0.0128
AC:
18717
AN:
1461862
Hom.:
140
Cov.:
36
AF XY:
0.0129
AC XY:
9350
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.00257
AC:
86
AN:
33480
American (AMR)
AF:
0.00642
AC:
287
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00429
AC:
112
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00780
AC:
673
AN:
86258
European-Finnish (FIN)
AF:
0.0138
AC:
736
AN:
53412
Middle Eastern (MID)
AF:
0.0260
AC:
150
AN:
5768
European-Non Finnish (NFE)
AF:
0.0144
AC:
15962
AN:
1111990
Other (OTH)
AF:
0.0117
AC:
709
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
1120
2240
3361
4481
5601
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
588
1176
1764
2352
2940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00918
AC:
1399
AN:
152356
Hom.:
13
Cov.:
33
AF XY:
0.00909
AC XY:
677
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.00248
AC:
103
AN:
41582
American (AMR)
AF:
0.00889
AC:
136
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
15
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00517
AC:
25
AN:
4832
European-Finnish (FIN)
AF:
0.0124
AC:
132
AN:
10624
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0137
AC:
933
AN:
68028
Other (OTH)
AF:
0.0156
AC:
33
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
73
147
220
294
367
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0115
Hom.:
38
Bravo
AF:
0.00874
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.0171
EpiControl
AF:
0.0187

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hereditary spastic paraplegia 39 (2)
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Hereditary spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
5.7
DANN
Benign
0.78
PhyloP100
2.7
PromoterAI
-0.014
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112133109; hg19: chr19-7623941; COSMIC: COSV55386447; COSMIC: COSV55386447; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.